SP
Sagar Pravinbhai Hirani
About Sagar Pravinbhai Hirani
Data last updated:
Sagar Pravinbhai Hirani is a Director at Symbiosis Bioscience Private Limited (since 2022), Director at Axter Pharmaceuticals Private Limited (since 2024) and Director at Laxter Pharmaceuticals Private Limited (since 2019), and holds 1 more current directorship. The companies operate in Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹9.07 Cr; the largest is Symbiosis Bioscience Private Limited at ₹4.13 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Symbiosis Bioscience Private Limited U24304GJ2022PTC134050 | Director | 20 Jul 2022 | 2022 | ₹4.13 Cr (FY 2025) | Active |
 Axter Pharmaceuticals Private Limited U24230GJ2014PTC080669 | Director | 10 Aug 2024 | 2014 | ₹3.43 Cr (FY 2025) | Active |
| Laxter Pharmaceuticals Private Limited U74999GJ2018PTC103970 | Director | 09 May 2019 | 2018 | ₹1.51 Cr (FY 2023) | Under Process Of Striking Off |
| Symbiosis Biolife Llp ACF-9952 | Designated Partner | 11 Mar 2024 | 2024 | Active |
Board colleagues of Sagar Pravinbhai Hirani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jagdish Pravinbhai Hirani | 06919912 | Symbiosis Bioscience Private Limited , Axter Pharmaceuticals Private Limited | Director |
| Kuldeep Kanaiyalal Ribadiya | 06919929 | Symbiosis Bioscience Private Limited , Axter Pharmaceuticals Private Limited | Director |
| Rushikumarkanaiyalal Ribadiya | 06919976 | Symbiosis Bioscience Private Limited , Axter Pharmaceuticals Private Limited and 1 more | Director |
| Sakshi Laller | 10163397 | Symbiosis Bioscience Private Limited , Symbiosis Biolife Llp | Director |
| Jagbir Singh | 00821561 | Laxter Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sagar Pravinbhai Hirani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sagar Pravinbhai Hirani
Sagar Pravinbhai Hirani currently holds 4 directorships: Symbiosis Bioscience Private Limited (Director, since 20 Jul 2022, revenue ₹4.13 Cr (FY 2025)); Axter Pharmaceuticals Private Limited (Director, since 10 Aug 2024, revenue ₹3.43 Cr (FY 2025)); Laxter Pharmaceuticals Private Limited (Director, since 09 May 2019, revenue ₹1.51 Cr (FY 2023)); Symbiosis Biolife Llp (Designated Partner, since 11 Mar 2024).
Sagar Pravinbhai Hirani was first appointed on 09 May 2019 as Director at Laxter Pharmaceuticals Private Limited. The most recent appointment on record is 10 Aug 2024 at Axter Pharmaceuticals Private Limited.
The 3 current companies of Sagar Pravinbhai Hirani that report revenue have a combined latest revenue of ₹9.07 Cr: Symbiosis Bioscience Private Limited ₹4.13 Cr (FY 2025); Axter Pharmaceuticals Private Limited ₹3.43 Cr (FY 2025); Laxter Pharmaceuticals Private Limited ₹1.51 Cr (FY 2023).
The current boards of Sagar Pravinbhai Hirani's companies include Jagdish Pravinbhai Hirani (Symbiosis Bioscience Private Limited), Kuldeep Kanaiyalal Ribadiya (Symbiosis Bioscience Private Limited), Rushikumarkanaiyalal Ribadiya (Symbiosis Bioscience Private Limited), Sakshi Laller (Symbiosis Bioscience Private Limited), Jagbir Singh (Laxter Pharmaceuticals Private Limited).